Prosecution Insights
Last updated: November 19, 2026
Application No. 19/064,892

SYSTEM AND METHOD FOR ANALYZING CORNEAL LESION USING ANTERIOR OCULAR SEGMENT IMAGE, AND COMPUTER-READABLE RECORDING MEDIUM

Non-Final OA §101§103
Filed
Feb 27, 2025
Priority
Dec 10, 2019 — RE 10-2019-0164182 +2 more
Examiner
TRANDAI, CINDY HUYEN
Art Unit
2648
Tech Center
2600 — Communications
Assignee
Samsung Life Public Welfare Foundation
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
8m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
423 granted / 540 resolved
+16.3% vs TC avg
Strong +18% interview lift
Without
With
+17.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
9 currently pending
Career history
546
Total Applications
across all art units

Statute-Specific Performance

§101
4.3%
-35.7% vs TC avg
§103
78.1%
+38.1% vs TC avg
§102
6.7%
-33.3% vs TC avg
§112
6.4%
-33.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 540 resolved cases

Office Action

§101 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 12 is rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. Claim 12 recites “a computer-readable storage device on which a program that performs the method” drawn to the computer readable medium that covers both transitory and non-transitory embodiments may be amended to narrow the claim to cover only statutory embodiments to avoid a rejection under 35 U.S.C. § 101 by adding the limitation "non-transitory" to the claim. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 7 and 12 are rejected under 35 U.S.C. 103 as being unpatentable over Boyd et al. US 20220207729 A1) in view of Abou Shousha et al. (US 20200035362 A1) hereinafter referred as Abou. Regarding claim 1, Boyd teaches a system for analyzing a corneal lesion using an anterior segment image, the system comprising: an image acquisition unit ([Fig. 3 and Par. 164, 193), 197) configured to acquire “ocular image” ([Fig. 3 and Par. 164, 193), 197); a feature extractor configured to extract feature information on a position and a cause of a lesion in a cornea of the eyeball from the anterior segment image (Fig. 5 and Pars. 262-263, 323, 504, bright dot(s) (lesion) in region (position) of interest(s) ROI(s)) by applying a convolution layer to the anterior segment image through machine learning (Fig. 48, the feature extraction layers such as convolutional layers and Par. 461) on the basis of a database in which clinical information pre-acquired (Fig. 4 and Pars. 6, 8, a database configured to store plurality of ocular images corresponds to a plurality of different imaging modalities) by analyzing positions and causes of lesions in the corneas of subjects is stored (Par. 222, feature extraction specific disease-relevant observations (to be compared against other modalities); and a result determination unit configured to identify a position of the cornea from the anterior segment image using the feature information and to analyze and determine the position and the cause of the lesion in the cornea from the position of the cornea (Fig. 28 and Pars. 353-354, 661-662, detection of macrophages, e.g. tumor-associated macrophages). Boyd does not explicitly teach the ocular image as taught above is an anterior segment image. However, this feature cannot be considered new or novel in the presence of Abou. Abou teaches input image data includes multiple images that capture a current state of a patient's cornea or anterior segment (Fig. 1B and Pars. 77, 95-96). Therefore, it would have been obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to incorporate the above teaching as taught by Abou into Boyd to improve accuracy of the prediction. Regarding claim 7, method of claim 7 is performed by the apparatus of claim 1. They recite similar limitations. Applicant is kindly advised to refer to rejection of claim 1. Regarding claim 12, computer-readable storage device of claim 12 is performed by the apparatus of claim 1. They recite similar limitations. Applicant is kindly advised to refer to rejection of claim 1. Claims 2-3 and 8-9 are rejected under 35 U.S.C. 103 as being unpatentable over Boyd et al. US 20220207729 A1) in view of Abou Shousha et al. (US 20200035362 A1) hereinafter referred as Abou and in further view of Huynh et al. (US 20210158132 A1). Regarding claim 2, the modified Boyd does not specifically teach claim 2. However, this feature cannot be considered new or novel in the presence of Huynh. Huynh teaches the system of claim 1, wherein the feature extractor comprises: a residual network (ResNet) obtained by stacking at least one network of a plurality of networks each including a convolution layer, a pooling layer, and an activation function or a rectified linear unit (ReLU) function and the ResNet extracts the feature information, including a multiple-channel feature map for extracting a suspicious region, from the anterior segment image (Fig. 2-3 and Pars. 39-44). Therefore, it would have been obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to incorporate the above teaching as taught by Huynh into the modified Boyd to improve the utilization rate using a small number of input channels. Regarding claim 3, the modified Boyd teach the system of claim 2, wherein the feature extractor comprises: a lesion guiding module configured to extract a lesion region more precise than the suspicious region through convolution of the feature information and positional data of a lesion in the clinical information, the positional data representing a position of the lesion (Pars. 262-263, selecting (extracting) ROIs in areas of disease activity & Note: the areas of interest give more weight (more precise)). Regarding claim 8, method of claim 8 is performed by the apparatus of claim 2. They recite similar limitations. Applicant is kindly advised to refer to rejection of claim 2. Regarding claim 9, method of claim 9 is performed by the apparatus of claim 3. They recite similar limitations. Applicant is kindly advised to refer to rejection of claim 3. Claims 4-5 and 10 are rejected under 35 U.S.C. 103 as being unpatentable over Boyd et al. US 20220207729 A1) in view of Abou Shousha et al. (US 20200035362 A1) hereinafter referred as Abou and in further view of Razali et al. (US 20220257115 A1). Regarding claim 4, the modified Boyd does not explicitly teach the system of claim 1, wherein the feature extractor comprises: a slit lamp mask adjustment module adjusting a slit beam image present in a region of the anterior segment image. However, this feature cannot be considered new or novel in the presence of Razali. Razali teaches change light profile to a slit mask for a spot or a slit for profiling light for eye examination ensure no image of the light source appears (excludes a slit lamp portion) on the eye of the patient (Fig. 14, Par. 72, 118). Therefore, it would have been obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to incorporate the above teaching as taught by Razali into the modified Boyd prevent image distortions or reflection. Regarding claim 5, the modified Boyd further teaches the system of claim 4, wherein the slit lamp mask adjustment module excludes a slit lamp portion from the anterior segment image and causes the position of the cornea or the position of the lesion in the cornea, which is included in the anterior segment image, to be learned (Pars. 472-475) Regarding claim 10, method of claim 10 is performed by the apparatus of claim 4. They recite similar limitations. Applicant is kindly advised to refer to rejection of claim 4. Claims 6 and 11 are rejected under 35 U.S.C. 103 as being unpatentable over Boyd et al. US 20220207729 A1) in view of Abou Shousha et al. (US 20200035362 A1) hereinafter referred as Abou and in further view of Isgum et al. (US 20190318476 A1). Regarding claim 6, the modified Boyd teach system of claim 1, wherein the result determination unit re-inputs a 3rd label feature vector output from the feature extractor and a prediction vector corresponding to a 2.sup.nd label feature vector computed by applying a fully connected layer to the 3rd label feature vector, into the fully connected layer and thus identifies the cause of the lesion in the cornea (region of the eye classified as a phenotype of one of normal, drusen, retinal pigment epithelium detachment, geographic atrophy, macular atrophy or neovascularization, based at least in part on classification of the cross-section image corresponding to that segment using a convolutional neural network (Pars. 63, 347-348) for the detection of macrophages, e.g. tumor-associated macrophages (Pars. 353-354), wherein the feature extraction layers such as convolutional layers [Wingdings font/0xE8]fully connected layers [Wingdings font/0xE8] output layer such as prediction output (Fig. 48)). The modified Boyd does not specifically express that the feature extracted from the convolution layers is known as “label feature vector” in the presence of Isgum (Par. 59). Therefore, it would have been obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to incorporate the above teaching as taught by Isgum into the modified Boyd for feature extraction. Regarding claim 11, method of claim 11 is performed by the apparatus of claim 6. They recite similar limitations. Applicant is kindly advised to refer to rejection of claim 6. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Hirokawa et al. US 12380557 B2 Miyamoto et al. US 9317918 B2 Yates et al. (US 20180055351 A1) (Pars. 61-64). Leung et al. US 20240074657 A1 [0031] In some embodiments, the SS position can be detected manually by a human grader, or automatically using a deep neural network model trained with deep learning. As illustrated in FIG. 5…… An example model architecture that can be implemented is ResNet-50. [0085] classifying each respective angle-location as either normal or abnormal based on one respective ACA parameter of the plurality of measured ACA parameters; [0086] calculating an extent of abnormalities with reference to the total number of abnormal angle-locations; and [0087] determining a risk of disease development for the eye from a regression model based on the extent of abnormalities. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CINDY HUYEN TRANDAI whose telephone number is (571)270-1914. The examiner can normally be reached 8am -4:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Wesley L. Kim can be reached at 571-272-7867. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Cindy Trandai/Primary Examiner, Art Unit 2648 10/28/2026
Read full office action

Prosecution Timeline

Feb 27, 2025
Application Filed
Oct 30, 2026
Non-Final Rejection mailed — §101, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12800745
DETERMINING WEIGHTS FOR COMBINING RANGING MEASUREMENTS AT DIFFERENT BANDWIDTHS
2y 7m to grant Granted Nov 17, 2026
Patent 12795757
BLUETOOTH DEVICE PAIRING CONNECTION METHOD, ELECTRONIC DEVICE, BLUETOOTH DEVICE, AND TERMINAL SYSTEM
3y 1m to grant Granted Nov 10, 2026
Patent 12779122
A wireless data communication accessory for a drug delivery device
4y 5m to grant Granted Nov 03, 2026
Patent 12785753
REUSABLE COMMUNICATION DEVICE FOR A CATHETER FOR RELEASABLE CONNECTION TO A CATHETER HUB OF THE CATHETER
3y 2m to grant Granted Nov 03, 2026
Patent 12757034
JUDGMENT METHOD AND WIRELESS COMMUNICATION APPARATUS
2y 8m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
96%
With Interview (+17.7%)
2y 4m (~8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 540 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month